RAPT Therapeutics Inc.

1.05
-0.09 (-7.89%)
At close: Mar 03, 2025, 3:59 PM
1.05
-0.47%
After-hours: Mar 03, 2025, 04:00 PM EST

RAPT Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Cash & Equivalents 47.48M 38.95M 24.03M 24.92M 77.38M 63.8M 47.52M
Short-Term Investments 111.38M 210.12M 165.63M 86.59M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a 598K 605K
Other Long-Term Assets 3.87M 4.04M 2.92M 389K 389K -209K -369K
Receivables n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 2.92M 3.63M 6.64M 8.18M 6.25M 1.26M 725K
Total Current Assets 161.78M 252.69M 192.97M 115.6M 80.51M 65.06M 48.24M
Property-Plant & Equipment 7.68M 9.48M 2.74M 2.98M 3.71M 4.16M 1.91M
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 11.55M 13.52M 5.66M 3.37M 4.1M 4.55M 2.15M
Total Assets 173.33M 266.21M 198.64M 118.97M 84.6M 69.61M 50.39M
Account Payables 5.18M 3.37M 2M 2.38M 1.14M 1.77M 1.11M
Deferred Revenue n/a n/a 1.02M 4.1M 4M n/a n/a
Short-Term Debt 2.45M 4.34M n/a n/a n/a n/a n/a
Other Current Liabilities 14.21M 6.52M 6.58M 5.26M 4.11M 2.87M 2.14M
Total Current Liabilities 21.84M 14.22M 9.6M 11.74M 9.26M 4.64M 3.25M
Long-Term Debt 4.46M 6.82M n/a n/a n/a n/a 108.64M
Other Long-Term Liabilities n/a n/a 2.15M 2.19M 2.23M 969K 905K
Total Long-Term Liabilities 4.46M 6.82M 2.66M 3.05M 2.23M 969K 109.55M
Total Liabilities 26.29M 21.04M 12.26M 14.79M 11.48M 5.61M 112.8M
Total Debt 6.91M 8.99M n/a n/a n/a 161.11M 108.64M
Common Stock 3K 3K 3K 2K 2K 2K 1K
Retained Earnings -484.68M -367.88M -284.05M -214.84M -161.95M -118.95M -82.81M
Comprehensive Income 103K -26K -206K -177K 20K -4K -3.77M
Shareholders Equity 147.03M 245.17M 186.38M 104.18M 73.12M 64M -62.41M
Total Investments 111.38M 210.12M 165.63M 86.59M n/a 598K 605K